(68 days)
No
The summary describes a standard OCT imaging system with a normative database for comparison. There is no mention of AI or ML algorithms for image analysis, diagnosis, or any other function. The focus is on the hardware upgrade for faster image acquisition.
No.
The device is clearly indicated as a "diagnostic device to aid in the detection and management of ocular diseases" and a "non-invasive diagnostic device for imaging." It is used for "in vivo imaging and measurement" and as a "quantitative tool for the comparison of retina, retinal nerve fiber layer, and optic disk measurements." It does not provide any treatment or therapy.
Yes
The "Intended Use / Indications for Use" section explicitly states, "It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases." Also, the "Device Description" section states that "The RTVue XR is a non-invasive diagnostic device".
No
The device description clearly states it is an "optical coherence tomography system" and a "non-invasive diagnostic device for imaging the cornea, anterior chamber, and retinal tissue structure". It describes hardware components like a low coherence interferometer, a computer with a graphic user interface, and a lens attachment (CAM). This indicates it is a hardware device with integrated software, not a software-only medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device description: The RTVue XR is described as a non-invasive diagnostic device that performs imaging and measurement in vivo (within the living body) of the eye's structures. It uses Optical Coherence Tomography (OCT) technology to scan the patient's eye directly.
- Intended Use: The intended use clearly states "in vivo imaging and measurement" and describes its use as a tool and aid in the diagnosis and management of retinal diseases by a clinician.
The device operates by directly interacting with the patient's eye, not by analyzing samples taken from the body. Therefore, it falls under the category of an in vivo diagnostic device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The RTVue XR with Normative Database is an optical coherence tomography system indicated for the in vivo imaging and measurement of the retinal nerve fiber layer, and optic disc as a tool and aid in the diagnosis and management of retinal diseases by a clinician. The RTVue XR with Normative Database is also a quantitative tool for the comparison of retina, retinal nerve fiber layer, and optic disk measurements in the human eye to a database of known normal subjects. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases.
Product codes
HLI
Device Description
The RTVue XR is a non-invasive diagnostic device for imaging the cornea, anterior chamber, and retinal tissue structure with micrometer range resolution. The RTVue XR OCT is based on the same Optical Coherence Tomography (OCT) technology used in its predicate device, RTVue with NDB OCT.
The RTVue XR is a computer controlled ophthalmic imaging system. The device scans the patient's eye using a low coherence interferometer to measure the reflectivity of the retinal tissue. The cross sectional retinal tissue structure is composed of a sequence of Ascans. It has a traditional patient and instrument interface like most ophthalmic devices. The computer has a graphic user interface for acquiring and analyzing the image.
RTVue XR offers three scan types: Retina, Glaucoma, and Cornea. For the Cornea scan, a lens must be attached to the front of the device for proper scanning. This lens is called the CAM (Cornea Anterior Module-cleared under K111505)
The upgrade of the line scan camera is designed to provide faster image acquisition. The RTVue XR is an updated version of RTVue with NDB that operates at ~70,000 A-lines per second while the RTVue-100 operates at ~27,000 A-lines per second. The RTVue XR machines will be equipped with new line-scan cameras capable of operating at ~70,000 Alines per second while delivering equivalent imaging results as the older generation RTVue line-scan cameras operating at ~27,000 A-lines per second.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Optical Coherence Tomography (OCT)
Anatomical Site
retinal nerve fiber layer, optic disc, retina, cornea, anterior chamber, human eye
Indicated Patient Age Range
Not Found
Intended User / Care Setting
clinician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Elliot lab Certification Testing and Report (ref: R64363 Rev.3 and R63863 Rev. 4) in accordance to IEC 60601-1 Amendment 1 and 2 and IEC-60601-1-2. In addition a Bench test was also performed, with the results for comparison of the RTVue XR with the predicate device RTVue with NDB. The RTVue XR meets the safety and stability requirements of IEC 60601-1and IEC-60601-1-2 as well as the bench test requirements results.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.1570 Ophthalmoscope.
(a)
Identification. An ophthalmoscope is an AC-powered or battery-powered device containing illumination and viewing optics intended to examine the media (cornea, aqueous, lens, and vitreous) and the retina of the eye.(b)
Classification. Class II (special controls). The device, when it is an AC-powered opthalmoscope, a battery-powered opthalmoscope, or a hand-held ophthalmoscope replacement battery, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
0
APR - 3 2012
Image /page/0/Picture/2 description: The image shows the word "optovue" in a stylized font. The "o" in "optovue" is a circle with a dot in the center, resembling an eye. There is a curved line above the word, connecting the "o" and the "e".
510(k) Summary Optovue, Incorporated
This 510(k) summary for the RTVue is submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92
General Information
Manufacturer:
Optovue, Inc. 45531 Northport Loop West, Fremont, CA 94538 Phone: (510) 623-8868 Fax: (510) 623-8668 Registration No .: 3005950902
Contact Person:
John J. Talarico VP Regulatory/Quality Assurance Optovue, Inc. Phone: (510)623-8868 x209 e-mail: john talarico@optovue.com
Device Information
Classification:
Trade Name:
Class II
RTVue>
Common Name:
RTVue XR Optical Coherence Tomography (OCT) Ophthalmoscope, a-c powered (21 C.F.R.
§ 886.1570)
Predicate Devices
Classification Name:
510(k) K101505 RTVue with NDB Optical Coherence Tomography (OCT)
Purpose of the Special 510(k) notice
The RTVue XR OCT is an upgrade to the current cleared device RTVue with NDB (K101505) with a new line scan camera for faster image acquisition.
Intended Use
45531 Northport Loop W. Fremont, CA 94538 Phone: (866) 344.8948; (510) 623-8868 Fax: (510) 623.8668
1
The RTVue XR with Normative Database is an optical coherence tomography system indicated for the in vivo imaging and measurement of the retinal nerve fiber layer, and optic disc as a tool and aid in the diagnosis and management of retinal diseases by a clinician. The RTVue XR with Normative Database is also a quantitative tool for the comparison of retina, retinal nerve fiber laver, and optic disk measurements in the human eye to a database of known normal subjects. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases.
Technological Characteristics
The RTVue XR is a non-invasive diagnostic device for imaging the cornea, anterior chamber, and retinal tissue structure with micrometer range resolution. The RTVue XR OCT is based on the same Optical Coherence Tomography (OCT) technology used in its predicate device, RTVue with NDB OCT.
The RTVue XR is a computer controlled ophthalmic imaging system. The device scans the patient's eye using a low coherence interferometer to measure the reflectivity of the retinal tissue. The cross sectional retinal tissue structure is composed of a sequence of Ascans. It has a traditional patient and instrument interface like most ophthalmic devices. The computer has a graphic user interface for acquiring and analyzing the image.
RTVue XR offers three scan types: Retina, Glaucoma, and Cornea. For the Cornea scan, a lens must be attached to the front of the device for proper scanning. This lens is called the CAM (Cornea Anterior Module-cleared under K111505)
The upgrade of the line scan camera is designed to provide faster image acquisition. The RTVue XR is an updated version of RTVue with NDB that operates at ~70,000 A-lines per second while the RTVue-100 operates at ~27,000 A-lines per second. The RTVue XR machines will be equipped with new line-scan cameras capable of operating at ~70,000 Alines per second while delivering equivalent imaging results as the older generation RTVue line-scan cameras operating at ~27,000 A-lines per second.
Performance Data
Elliot lab Certification Testing and Report (ref: R64363 Rev.3 and R63863 Rev. 4) in accordance to IEC 60601-1 Amendment 1 and 2 and IEC-60601-1-2. In addition a Bench test was also performed, with the results for comparison of the RTVue XR with the predicate device RTVue with NDB. The RTVue XR meets the safety and stability requirements of IEC 60601-1and IEC-60601-1-2 as well as the bench test requirements results.
Substantial Equivalence
The RTVue XR has the same intended use and similar indications, principles of operation, and technological characteristics as the RTVue with NDB OCT. The minor difference in the RTVue XR OCT is a new line scan camera for faster image acquisition and this upgrade does not raise any new questions of safety or effectiveness. Performance data demonstrates that the RTVue XR is as safe and effective as RTVue with NDB OCT. Thus, the RTVue XR is substantially equivalent to its predicate devices.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, often associated with medicine and healthcare. The symbol is positioned to the right of a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA".
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring. MD 20993-0002
Optovue, Inc c/o Mr. John Talarico VP Regulatory and Clinical Affairs 45531 Northport Loop W. · Fremont, CA 94538
Re: K120238
Trade/Device Name: RTVue XR OCT Regulation Number: 21 CFR 886.1570 Regulation Name: Ophthalmoscope Regulatory Class: Class II Product Code: HLI Dated: February 23, 2012 Received: February 27, 2012
APR - 3 2012
Dear Mr. Talarico:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical Of Ice-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
3
Page 2 - Mr. John Talarico
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Kesia Alexander
Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Image /page/4/Picture/0 description: The image shows the word "optovue" in a stylized font. The "o" in "optovue" is replaced with an image of an eye. There is a curved line above the word "optovue".
Indications for Use Statement
K120238 510(k) Number (if known):
Device Name: RTVue XR
Indications for Use:
The RTVue XR with Normative Database is an optical coherence tomography system indicated for the in vivo imaging and measurement of the retinal nerve fiber layer, and optic disc as a tool and aid in the diagnosis and management of retinal diseases by a clinician.
The RTVue XR with Normative Database is also a quantitative tool for the comparison of retina, retinal nerve fiber layer, and optic disk measurements in the human eye to a database of known normal subjects. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases.
Prescription Use (Per 21 C.F.R. 801.109) AND/OR
Over-The-Counter Use (Per 21 C.F.R. 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Aem
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number K120238